Anti-Human CD5 [UCHT-2] In Vivo Antibody - Low Endotoxin
- SKU:
- IVMB0309
- Product Type:
- In Vivo Monoclonal Antibody
- Clone:
- UCHT-2
- Protein:
- CD5
- Isotype:
- IgG1
- Reactivity:
- Human
- Synonyms:
- Leu-1
- Synonyms:
- Ly-1
- Synonyms:
- T1
- Synonyms:
- Tp67
- Research Area:
- Costimulatory Molecules
- Research Area:
- Immunology
- Endotoxin Level:
- Low Endotoxin
- Host Species:
- Mouse
- Applications:
- FA
- Applications:
- FC
- Applications:
- IHC FF
- Applications:
- In Vivo
- Applications:
- PhenoCycler
Description
Product Name: | Anti-Human CD5 (Clone UCHT-2) In Vivo Antibody - Low Endotoxin |
Product Code: | IVMB0309 |
Size: | 1 mg, 5 mg, 25 mg, 50 mg, 100 mg |
Clone: | UCHT-2 |
Protein: | CD5 |
Product Type: | Monoclonal Antibody |
Synonyms: | Leu-1, Ly-1, T1, Tp67 |
Isotype: | IgG1 |
Reactivity: | Human |
Applications: | FA, FC, IHC FF, In Vivo, PhenoCycler® |
Formulation: | This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration. |
Endotoxin Level: | < 1.0 EU/mg as determined by the LAL method |
Purity: | ≥95% monomer by analytical SEC ⋅ >95% by SDS Page |
Product Preparation: | Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. |
Applications: | FA, FC, IHC FF, In Vivo, PhenoCycler® |
Reactivity: | Human |
Host Species: | Mouse |
Specificity: | Mouse Anti-Human CD5 (Clone UCHT-2) recognizes Human CD5. This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype. Anti-Human CD5 recognizes a human T-lymphocyte surface membrane antigen (Mr 67 kDa). |
Antigen Distribution: | The CD5 antigen is present on approximately 70% of normal peripheral blood lymphocytes and >90% of all T-lymphocytes. T-lymphocytes in the thymus stain weakly while peripheral T-cells stain strongly. Monocytes, granulocytes and NK cells are not stained.1 Anti-CD5 also reacts with a distinct subset of normal B-lymphocytes, occasional cells in B-lymphocyte areas of spleen and lymph node, and most Ig+ B-chronic lymphoblastic leukemia (CLL) cells. The CD5 antigen has also been shown to be present on some lymphomas. |
Concentration: | ≥ 5.0 mg/ml |
Endotoxin Level: | < 1.0 EU/mg as determined by the LAL method |
Formulation: | This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration. |
Purity: | ≥95% monomer by analytical SEC ⋅ >95% by SDS Page |
Preparation: | Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. |
Storage and Handling: | Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles. |